Blog
RSS FeedPosted by Michael Wonder on 15 Nov 2019
Valeo Pharma announces filing of a new drug submission for low molecular weight heparin in Canada
14 November 2019 - Valeo Pharma announced today that the new drug submission filed for a low molecular weight heparin ...
Posted by Michael Wonder on 12 Nov 2019
'Incredibly upsetting': breast cancer patients dealing with shortage of common drug treatment
12 November 2019 - When Tricia Smith tried to fill her prescription for tamoxifen two weeks ago, she was shocked ...
Posted by Michael Wonder on 09 Nov 2019
Xeomin Cosmetic licensed for additional indications In Canada
7 November 2019 - Merz Pharma has announced that Health Canada has provided marketing authorization for additional indications for Xeomin ...
Posted by Michael Wonder on 09 Nov 2019
Janssen announces Health Canada approval of Imbruvica (ibrutinib) in combination with obinutuzumab for treatment naïve patients with chronic lymphocytic leukaemia
8 November 2019 - Patients experienced a 77% reduction in risk of disease progression or death compared to chlorambucil plus obinutuzumab. ...
Posted by Michael Wonder on 07 Nov 2019
Endoceutics receives Health Canada approval for Intrarosa
6 November 2019 - The first innovative drug for the treatment of vulvovaginal atrophy with prasterone. ...
Posted by Michael Wonder on 06 Nov 2019
Canadian ambassador says drug imports would not lower U.S. prices
2 November 2019 - Canada does not have a large enough supply of prescription drugs to meet U.S. demand, and ...
Posted by Michael Wonder on 31 Oct 2019
Janssen announces Health Canada approval of Darzalex (daratumumab) in combination with lenalidomide and dexamethasone for newly diagnosed patients with multiple myeloma who are transplant ineligible
30 October 2019 - This Darzalex combination regimen reduced the risk of disease progression or death by 44% in newly ...
Posted by Michael Wonder on 29 Oct 2019
Costly prescription eye treatment highlights a loophole in Canada’s drug-price regulation process
28 October 2019 - The Ontario government has begun covering $100,000-a-year eye drops for an ultrarare disease, bringing relief to ...
Posted by Michael Wonder on 28 Oct 2019
It’s time for Canada to embrace universal pharmacare and protect drug coverage from corporate erosion
28 October 2019 - President Trump recently unveiled an executive order — originally titled “Protecting Medicare from Socialist Destruction” — ...
Posted by Michael Wonder on 24 Oct 2019
Women living with metastatic breast cancer in British Columbia now have public access to Kisqali
23 October 2019 - Novartis Pharmaceuticals Canada is pleased to announce that British Columbia will now reimburse Kisqali (ribociclib) for eligible ...
Posted by Michael Wonder on 24 Oct 2019
Knight Therapeutics and SIFI announce approval of Netildex in Canada
23 October 2019 - Knight Therapeutics and SIFI today announced that Health Canada has approved Netildex for the treatment of inflammatory ...
Posted by Michael Wonder on 23 Oct 2019
Canadian election clears path for universal drug plan
23 October 2019 - Canada’s Liberal government is more likely to pass a universal prescription drug plan after losing its majority ...
Posted by Michael Wonder on 23 Oct 2019
Patients in Quebec now have access to Dupixent for the treatment of moderate-to-severe atopic dermatitis
22 October 2019 - Quebec becomes the first province to list Dupixent for public reimbursement in adult patients. ...
Posted by Michael Wonder on 22 Oct 2019
Which health care promises will the Liberals realistically be able to keep?
22 October 2019 - The Liberals have a number of significant health care-related campaign promises to live up to as ...
Posted by Michael Wonder on 22 Oct 2019
Trump urges quicker action to allow imported drugs from Canada
22 October 2019 - U.S. President Donald Trump on Monday called on U.S. Health Secretary Alex Azar to speed up ...